IL1B and Parkinson disease: MCC950 attenuates the inflammatory response and reduces murine nigrostriatal inflammatory response through inhibition of NLRP3/IL-1β pathway and reduces hyperphosphorylated α-syn aggregates in the mouse substantia nigra striata thereby protecting dopaminergic neurons and ameliorating PD (Cheng et al., 2020).